Certain strains of various microbial species, including Staphylococcus aureus, produce polysaccharide capsules exterior to their cell wall. There is convincing evidence that capsules function as significant virulence factors (24, 34) . The increased virulence of encapsulated S. aureus correlates well with their ability to resist phagocytosis (15, 20) . However, the mechanism by which encapsulated S. aureus strains resist phagocytosis has not been fully elucidated.
For phagocytic cells to perform their bactericidal function, they must first be able to recognize the staphylococcus. Recognition is dependent upon the interactions of serum opsonins with the S. aureus cell surface and with receptors in the plasma membrane of the phagocyte. The opsonins act as ligands joining the surfaces of the two cell types and thereby inducing the attachment and ingestion phases of phagocytosis. It is believed that bacterial phagocytosis by polymorphonuclear leukocytes is mediated by leukocyte plasma membrane receptors interacting with the Fc portion of immunoglobulin G (IgG) and an activated form of the third component of complement (C3b) bound to the surface of the bacterium (22, 26, 30) .
The ability of encapsulated microorganisms to resist phagocytosis could be explained by two hypotheses (34) . The first hypothesis proposes that the capsule is freely permeable to opsonins, in which case their interaction with phagocytic cells must somehow be impeded, perhaps by the capsule covering over bound opsonins. Support for this hypothesis has come from several recent investigations. It is known that C3 becomes cell surface associated in encapsulated S. aureus after incubation of organisms in normal human serum (19) . A subsequent immunoelectron microscopic investigation suggests that C3 becomes localized at the cell wall of encapsulated S. aureus M (35) . Studies of encapsulated Cryptococcus neoformans (14) and Streptococcus pneumoniae (36) suggest that the capsules of these organisms are readily penetrated by opsonins.
The second hypothesis proposes that the capsule prevents serum opsonins from binding to the organism. In this case the capsule would represent a physicochemical barrier to serum opsonic factors. In support of this hypothesis, Verbrugh et al. (29) The disposable minicolumn was prepared by adding swollen Sephadex beads that had been equilibrated in PBS to a 5-ml plastic syringe with needle attached (Plastipak LUER-LOK Tip; Becton, Dickinson & Co., Rutherford, N.J.). The column was calibrated with blue dextran (Pharmacia Fine Chemicals, Inc. Piscataway, N.J.) and dinitrophenyl ornithine (Sigma). One milliliter of radioiodination reaction mixture was applied to the column, and the column was allowed to run dry. Next, 0.65 ml of PBS was applied to the column, and the eluate was discarded. The radioiodinated IgG was eluted by adding 1.3 ml of PBS, and the column eluate was collected. The concentration of IgG was determined spectrophotometrically by taking absorbance readings at 280 nm and comparing them to a previously prepared calibration curve relating IgG concentration to absorbancy at 280 nm. The purity of the IgG was assessed before and after radiolabeling by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, which revealed one band migrating identically in both cases.
IgG binding assay. The washed cells were suspended in 10 ml of PBS. The turbidity of suitable dilutions of the suspension was measured at 580 nm with a Spectronic 20 spectrophotometer (Bausch & Lomb Inc., Rochester, N.Y.). The concentration of orgnim was calculated from a previously prepared standard curve relating absorbancy at 580 nm to colony-forming units (CFU). The suspension was adjusted to 10'°CFU/ml, and appropriate dilutions of this suspension were used to provide the required number of CFU for the assay mixtures.
Binding studies were carried out at 0°C in disposable 1.5-ml polypropylene microcentrifuge tubes with attached caps (West Coast Scientific, Inc., Oakland, Calif.) by mixing 1 ug of radiolabeled IgG in 25 Ml of PBS with 200 pl of bacterial suspension. After 30 min the mixture was centrifuged in a Beckman Microfuge B centrifuge (Beckman Instruments, Inc., Fullerton, Calif.) for 1 min. The supernatant was aspirated off, and the radioactivity of the bacterial pellet was determined in a Beckman Gamma 4000 gamma radiation counter. The bound IgG was expressed as percent total radioactivity added. Repeated washing of the pellet with buffer failed to remove significant amounts of radioactivity. Hence, it was deemed unnecessary to wash the pellets before counting (13 Fig. 2 and 3 ). Similar findings are shown in Fig. 3 to ensure an excess of binding sites (16) . In an effort to measure early association events at less than 1 min, a vast excess of unlabeled IgG was added to the mixtures before centrifuging to terminate the binding (16) . Figure 4 shows that there was little difference in the rates of binding of IgG to the M strain and the M variant strain after the shortest incubation time (20 s), even at 00C. Similar amounts of "2'I-labeled IgG were bound to the M and M variant strains. Hence, the reaction must be so rapid that we were unable to measure binding kinetics in our experimental system. Similar results were obtained with the Smith diffuse and Smith compact strains (data not shown). Thus, we were unable to observe any barrier effect of the capsule to IgG binding. DISCUSSION Protein A in S. aureus is found predominantly in covalent linkage to cell wall peptidoglycan (23) and is uniformly distributed throughout the cell wall (9) . The encapsulated S. aureus strains M and Smith diffuse have been shown to contain protein A by Forsum et al. (5), who used a hemagglutination assay of extracted protein A with sensitized sheep erythrocytes. In the present investigation we have taken advantage of this fact to study the passage of IgG through the S. aureus capsular layer to IgG-binding protein A located in the cell wall. The encapsulated strains bound IgG in large amounts and, in fact, had somewhat higher binding capacities than did their unencapsulated variants in most experiments. These observations suggested that IgG was passing through the capsular layer readily.
Trypsin is known to digest protein A and hence reduces the IgG binding capacity of S. aureus strains (31) strains would be observable. We were unable to detect any differences in the rates of IgG binding to encapsulated and unencapsulated strains. After only 20 s of incubation at 00C, encapsulated and unencapsulated strains had bound maximum amounts of IgG. The rapid reaction between IgG and protein A-containing S. aureus has been noted previously (13) . Although differences in binding kinetics at very short times of incubation may exist, it seems that the capsule does not significantly restrict the passage of IgG through this layer. This finding is in accord with theoretical considerations of the characteristics of capsules as physicochemical barriers (3) .
The roles of bacterial capsules as diffusion barriers, molecular sieves, and adsorbents have been lucidly discussed by Dudman (3) . The concentration of polysaccharide in bacterial capsules appears to be on the order of 1.5 to 2.0%, and capsules may be considered as gels. Little decrease in diffusion rates in gels of this concentration occurs compared with rates in solution. Polyanionic capsules may immobilize cationic proteins (27) , but this does not appear to be an important consideration here because IgG binding to protein A was observed in encapsulated strains.
The most significant factor influencing the penetrability of capsules appears to be the size of the pores and channels in the three-dimensional gel network through which molecules must diffuse. The pore diameters in 1 and 2% agar have been estimated to be 95 and 44 nm, respectively (1). IgG is reported to have the dimensions of 3.5 by 15 nm (17) . Thus, IgG is expected to pass readily through the pores in bacterial capsules if they are the same size as those predicted from study of another polysaccharide gel, agar. The findings in this paper are in accord with the report that the S. aureus capsule is freely permeable to lysostaphin, a protein of much lower molecular weight than IgG (11) . However, the S. aureus capsule apparently excludes bacteriophage which have a head diameter of about 100 nm (32) .
A mechanism of resistance to phagocytosis in encapsulated S. aureus has been proposed recently (35) . In this study it was found that C3 became localized at the cell wall when an encapsulated S. aureus strain was incubated in normal human serum. S. aureus cell walls are known to be active in complement consumption (33) . In normal human serum complement activation by encapsulated strains is predominantly by the classical pathway (19) . Activation ofthe classical pathway probably involves IgG or IgM binding (or both) to the cell wall followed by binding of the first component of complement (Clq), which has a molecular weight of 400,000 (21) . Thus, it would be predicted that the capsule must be penetrated by IgG and Clq. The results reported in this paper confirm the prediction that the capsule is readily penetrated by IgG and as such provide support for the proposed mechanism of resistance to phagocytosis (35) .
It remains to be determined whether the S. aureus capsule allows the ready access of IgM to the cell wall. This molecule is larger than IgG, having a diameter of 30 to 37.5 nm (17) .
The results presented here also have implications for the underlying mechanism of the phenomenon of antigen masking in encapsulated bacteria. Encapsulated E. coli (K strains) are inagglutinable by 0 antisera directed against outer membrane lipopolysaccharide (18) . Similarly, the microcapsule of the S. aureus T strain renders this organism inagglutinable by anti-cell wall antibodies (37) . Removal of E. coli K antigen either by heating or enzymatically allows the strains to be agglutinated in homologous anti-O antiserum (18, 25) . The capsule may interfere with agglutination by preventing lattice formation between adjacent bacteria. Perhaps antibodies pass through the capsular layer, bind to cell wall antigens, and become covered over by the capsule. Thus, the cell wall-bound antibodies are not exposed at the true surface of the bacterium and are unable to participate in lattice formation. Ceppellini and Landy (2) showed that erythrocytes coated with bacterial capsular polysaccharides were no longer agglutinated by antibodies directed against erythrocyte surface antigens. They concluded that their data favored lack of agglutination being due to interference with lattice formation rather than prevention of antibody uptake. The findings of the present study also suggest possible mechanisms for diffuse colony formation in serum soft agar and for negative clumping factor reaction in encapsulated S. aureus strains (B. J. Wilkinson, submitted for publication).
In summary, this study has shown that the S. 
